Corneal vascular neoplasms (hemangioma and hemangiosarcoma) are rare in all species. Reported cases are single case reports in a single species. Archived cases of corneal hemangioma and hemangiosarcoma from dogs, cats, and horses were obtained from the Comparative Ocular Pathology Lab of Wisconsin (COPLOW, Madison, WI), tabulated, and examined. This retrospective study describes the breeds, ages, tumor types, and characteristics of vascular neoplasms that appeared to be primarily corneal in location, in feline, canine, and equine patients, with gross and histologic images. There is a discussion of predisposing factors and speculated association with chronic ocular surface disease.
| INTRODUCTION
Both inflammatory and neoplastic diseases can involve pathologic vascular proliferation of the normally nonvascular cornea (corneal neovascularization). Angiogenesis and inflammation share many common pathways and molecular mechanisms. Inflammation can stimulate angiogenesis, and angiogenesis can stimulate inflammation; both mechanisms may be involved in carcinogenesis. 1 There is increasing evidence that a chronic inflammatory state on the ocular surface may predispose to the development of corneal neoplasia, including vascular neoplasms. The cornea is unique as it is one of only two normally nonvascular mesenchymal or connective tissues in the body, the other being cartilage. 2 Although there are some species with a vascularized cornea, such as the Florida manatee, 3 the majority of veterinary species, as well as humans, have an avascular cornea. There are no physical barriers that separate the vascularized sclera from the nonvascular cornea. Maintenance of avascularity is an active process known as corneal angiogenic privilege. 4 The pathogenesis behind the maintenance of the cornea in a nonvascular state is only partially understood. Anti-angiotic factors that have been identified in the cornea include thrombospondins 1 and 2, endostatin, angiostatin, pigment epithelium-derived factor, and matrix metalloproteinases (MMPs). 5 Any vascularization of the cornea in a species with a normally nonvascular cornea is associated with a pathologic state, such as injury, hypoxia, or inflammation. The process of angiogenesis has been an important area of research focus because of its fundamental importance in tissue development, vascular diseases, and cancer. Corneal angiogenesis has been extensively studied because of its negative effect on vision and increased risk of corneal graft rejection. 5 Corneal angiogenesis is thought to be initiated by a disequilibrium between angiogenic and antiangiogenic factors that normally keep the cornea in an avascular state. 6 Blood vessel growth is mediated by many growth factors including VEGF, basic fibroblastic growth factor, and interleukin-8. 7, 8 Following resolution of corneal disease, most of the new vessels will regress, again through mechanisms that are incompletely understood, but there is often persistence of a proportion of the new blood vessels on or in the cornea. These "ghost vessels" can be detected clinically and histologically. 5 There are many therapeutic interventions which either prevent the formation of blood vessels, initiate regression once they are formed, or are used to ablate new blood vessels. Each method has varying degrees DOI: 10.1111/vop.12571 of efficacy. No single treatment modality is one hundred percent effective at preventing or treating corneal neovascularization, and many have undesirable side effects such as corneal scarring that decreases vision clarity. Combinations of therapeutic agents have so far shown the most promise and efficacy in limiting corneal neovascularization. 5 Factors that induce a change in the DNA that make cells predisposed to neoplastic transformation are known as "initiation factors." These initiators are irreversible and can persist in otherwise normal tissue indefinitely until the occurrence of a second type of DNA alteration, "promotion," occurs. 6 DNA damage secondary to ultraviolet light exposure is a type of initiation factor. Promotion can result from exposure of initiated cells to chemical irritants, hormones, growth factors, and cytokines released at the site of wound healing, or chronic inflammation. Many promoters directly or indirectly induce cell proliferation, recruit inflammatory cells, increase production of reactive oxygen species leading to oxidative DNA damage, and reduce DNA repair. Disruption of cell death and/or repair programs may occur in chronically inflamed tissues, resulting in DNA replication and proliferation of cells that have lost normal growth control. The processes of angiogenesis and inflammation are regulated by many overlapping molecular mechanisms. Both inflammation and angiogenesis have been shown to be involved in carcinogenesis, creating a cyclical and overlapping triangle of angiogenesis, inflammation, and neoplasia. Multiple risk factors have been identified that increase the incidence of vascular neoplasia of the facial region. Increased exposure to ultraviolet (UV) light has been shown to be a risk factor for the development of vascular tumors of the cornea, bulbar conjunctiva, eyelids including the third eyelid, periocular skin, and skin of the dorsal head, muzzle, and ears in domestic species and research animals. [9] [10] [11] [12] [13] [14] [15] [16] [17] Corneal damage from UV light is represented microscopically by solar elastosis, which appears as a laminar band of dissolution of the superficial collagen fibers and deposition of elastin, which has a blue tinge on hematoxylin and eosin staining, similar to what is seen in dermal collagen with solar elastosis. 15, 17 Chronic inflammation has also been implicated as a predisposing factor for the development of corneal neoplasia. Dreyfus et al noted in a case series of dogs with corneal squamous cell carcinoma that the majority of canine patients had a history of chronic keratitis and treatment with immune-suppressive or immune-modulating drugs (prednisone and cyclosporine), indicating an increased risk of developing corneal squamous cell carcinoma in these patients. 18 Corneal B-cell lymphoma was also described in a horse with chronic immune-mediated keratitis; neoplastic transformation of resident inflammatory cells was suspected. 19 Vascular neoplasms of the cornea are rare in all species. Most vascular neoplasms involving the cornea and sclera are secondary to conjunctival, limbal, or intraocular extension. [20] [21] [22] [23] Rarely, a vascular tumor is situated centrally on cornea, with no discernible attachment or origin from the sclera, and as such, these tumors appear to be primary/spontaneous to the cornea. This is an unusual and unexpected presentation because of the complex homeostatic mechanisms present that normally maintain an avascular state. Published cases of canine primary ocular corneal vascular neoplasia include a single case report of corneal hemangiosarcoma in a German shepherd 23 and two cases mentioned in a larger case series of visceral and nonvisceral hemangiosarcoma. 24 The German shepherd had a history of chronic uveitis, as well as UV exposure from being housed outdoors. The tumor was successfully removed via keratectomy with clean margins, with no recurrence at 3 months postoperatively. In the second publication, one patient had suspected metastatic disease under the tongue, and the other was euthanized after rapid tumor recurrence. 24 Feline corneal vascular tumors published in the literature are predominantly primary scleral, conjunctival, or eyelid masses with corneal involvement, rather than primary corneal neoplasms. Only 2 individual case reports of corneal vascular tumors were identified in the literature. 25, 26 One case also had concurrent corneal squamous cell carcinoma in addition to corneal hemangiosarcoma (collision tumors). 25 Published cases of primary equine corneal vascular neoplasia were not identified in a literature search. Vascular neoplasms are often described as "ocular origin," and the cornea is secondarily involved via extension from the limbal, perilimbal or palpebral conjunctiva, or third eyelid. [27] [28] [29] [30] The terms "angioma" and "angiosarcoma"
are often used when it cannot be determined whether a neoplasm is of vascular or lymphatic origin. This retrospective study consists of 14 cases of corneal vascular neoplasia (hemangioma and hemangiosarcoma) in dogs, 5 cases in cats, and 3 cases in horses which were identified from the archives of the Comparative Ocular Pathology of Wisconsin (COPLOW) laboratory in Madison, Wisconsin. Data by case and species were tabulated and compared. This case series will represent the only known published cases of primary corneal vascular neoplasia in horses, and the largest series of cases in dogs and cats.
| MATERIALS AND METHODS
Cases of benign and malignant corneal vascular neoplasia in dogs, cats, and horses were identified from the archives of the Comparative Ocular Pathology Lab of Wisconsin (COPLOW, Madison, WI) by performing a data search for cases in which the microscopic interpretation included the terms "hemangioma" or "hemangiosarcoma" and "cornea". A case was defined as a single patient with submission of a globe or keratectomy sample affected by corneal vascular neoplasia with limited or no limbal involvement grossly or histologically. In this case series, a mass was considered of primary corneal origin if less than 10% of the total tumor mass was present on the limbus or sclera, assessed grossly and histologically. This criterion was thought appropriate based on clinical experience of two authors (LBCT and RRD) and their inclusion criteria for cases in their database. Each histopathology sample was reviewed by a single pathologist (AMS) who confirmed the microscopic interpretation provided on each biopsy report previously written at COPLOW and that the degree of scleral or limbal attachment fits the definition of a primary corneal neoplasm. Only cases with convincing evidence of blood vessel origin by microscopic examination (neoplastic cells forming vascular spaces filled with blood) or immunohistochemistry were included in this study. No cases of lymphangioma or lymphangiosarcoma were included.
For each case, clinical data were collected and tabulated from the submission forms provided by the referring veterinarian, the biopsy report issued by COPLOW, and followup/confirmatory examination of the histology sample and gross photographs for each case. Data collected and tabulated included species, age, breed, what ocular tissue was submitted (whole globe versus keratectomy sample, left versus right eye), clinical history including duration of disease and the presence or absence of pre-existing ocular inflammation (as stated by the submitting veterinarian in the clinical history box on the requisition form), the presence or absence of microscopic inflammatory disease or solar elastosis, and morphologic diagnosis or diagnoses.
Microscopically, a tumor was classified as a hemangioma if it was composed of a proliferation of minimally to mildly pleomorphic endothelial cells forming well-organized simple to tortuous or cavernous vascular spaces containing erythrocytes. Vascular spaces may contain fibrin thrombi and fibrosis with mixed inflammation including hemosiderophages and mast cells. Mitotic figures were rare (typically 1 or fewer per 10 4009 fields, no more than 2 per 10 highpower fields). Tumors were discrete with minimal infiltration into the surrounding tissue or corneal stroma.
Hemangiosarcomas were differentiated from benign tumors microscopically based on greater cellularity and disorganization, a greater degree of cellular and nuclear pleomorphism, higher mitotic count, and depth of corneal infiltration. Vascular spaces were typically poorly organized and coalescing and lined by plump pleomorphic neoplastic cells with a "hobnail" configuration of nuclear protrusion into the vascular lumens. Neoplastic cells were sometimes organized in multiple layers versus the single layer of neoplastic cells that form the vascular spaces of hemangiomas. Mitotic count varied but was typically more than 5 per 10 4009 fields and never less than 3 per 10 4009 fields.
Other microscopic findings indicating pre-existing or concurrent ocular disease were also noted, including the presence of keratitis, solar elastosis, corneal epithelial hyperplasia or dysplasia, conjunctivitis, corneal neovascularization, chronic ocular surface disease with granulation tissue proliferation (pannus), and intraocular inflammation including pre-iridal fibrovascular membrane and uveitis.
Immunohistochemistry for factor VIII was performed on one case of canine hemangiosarcoma.
| RESULTS
There were 14 canine cases, 5 feline cases, and 3 equine cases of primary corneal hemangioma or hemangiosarcoma found out of 27 565 total case submissions spanning an eight-year period from 2007 through 2015. Case submissions to the COPLOW laboratory between and including years 2007-2015 for canines were 21 531, for cats were 5536, and for horses were 498 cases, representing a percentage of 14/21 531 or 0.07% of total canine case submissions, 5/5536 or 0.09% of feline case submissions, and 3/498 or 0.60% of equine case submissions. Across all 3 species, the total number of primary corneal vascular neoplasia cases is 22/27 565 or 0.08% of all cases submitted to COPLOW from 2007 through 2015.
| Canine vascular tumors from COPLOW archives
Data for canine cases are presented in Table 1 . Fourteen cases of primary corneal vascular neoplasia were identified from 2007 to 2015. Dogs were middle-aged to older, ranging from 7 to 14 years old, and averaged 9.9 years old. Two of 14 were mixed-breed (10.5%), 2 of 14 (10.5%) Australian shepherds, 2 of 14 (10.5%) German shepherds, and 2 of 14 (10.5%) Shetland sheepdogs; the remainder were single cases of one breed. Reported duration of disease was 1 month to 3.5 years. Eight of 14 had a history of pre-existing/coexisting ocular inflammation including chronic keratitis and/or conjunctivitis including chronic ocular surface disease with granulation tissue proliferation (pannus) or keratoconjunctivitis sicca (KCS)(6 cases), phthisis bulbi (1 case), and intraocular inflammation (preiridal fibrovascular membrane and hypermature cataract, 1 case), based on clinical information provided on the sample submission form. An additional 2 dogs had microscopic evidence of solar elastosis in the cornea, and one had Seven samples were keratectomy samples, and 7 were entire globes, 1 with eyelids including the third eyelid. Seven of 14 cases (50.0%) were interpreted as hemangiosarcomas, and the other 7 cases were interpreted as hemangiomas (50.0%). Grossly, there were central or eccentric (but still confined to the cornea with less than 10% involvement of the limbus) raised red hemorrhagic masses with associated corneal edema (Figures 1, 2 , and 3). Nine masses were asymmetrically placed (9/14, 64.3%), and there was attachment to/association with the limbus; the other 5 masses were centrally located on the cornea with no apparent limbal attachment or association observed grossly or histologically (5/14, 35.7%). Of centrally placed masses without limbal attachment, 4 of 5 (80.0%) were hemangiomas. In cases with a previous history of ocular surface disease, 6 had benign tumors, and 2 were malignant. In one case, in which immunohistochemistry was performed, tumors cells were positive for factor VIII, confirming an endothelial origin of the neoplastic cells. No follow-up information was available for any of these cases.
| Feline vascular tumors from COPLOW archives
Data for cases of feline vascular neoplasia are presented in Table 2 . Five cases of feline corneal vascular neoplasia were identified in the 8-year time span. Cats were middleaged to adult, ranging from 7 to 10 years old, with an average age of 8.8 years. Four cats were domestic shorthair, and one was a domestic medium-hair. Duration of disease was listed as weeks to 18 months. Four cases had a history of pre-existing ocular inflammation as per provided clinical history on the submission form. The last case had lymphoplasmacytic episcleritis histologically. Grossly and microscopically, tumors appeared like those in dogs. Four cases had a clinical history of pre-existing corneal disease or trauma as per the submission form. Two cases specifically mention abnormal vascular proliferation in the form of granulation tissue or organizing vascular proliferation.
All 5 cases were whole globe submissions (one following keratectomy with incomplete excision; this was counted as a single case). Four cases were hemangiosarcomas (4/5, 80.0%), and 1 was interpreted a hemangioma (1/5, 20.0%). Two cases had limited (less than 10%) limbal attachment (2/5 or 40.0%), and 3 were centered on the cornea (3/5 or 60.0%). 
| Equine vascular tumors from COPLOW archives
Data for equine cases are provided in Table 3 . Three cases of primary vascular corneal neoplasia were identified in equids (2 horses, 1 mule). Ages ranged from 9 to 21 years, with an average age of 13.3 years. The one horse for which breed was provided was an Arabian. Duration of corneal masses was 9 months to 2 years (only two cases had information available). One case had a prior biopsy report of hemangiosarcoma. There was no clinical history of pre-existing ocular surface disease mentioned for any case. Each mass had peripheral attachment to the limbus, but less than 10% of the tumor mass was present there. Two samples were entire globes, one with the third eyelid, and the third was a keratectomy sample. All three tumors were interpreted as hemangiosarcoma based on histologic features of the neoplastic cells. One case also had suspected concurrent squamous cell carcinoma; immunohistochemistry was recommended but not performed. One globe was an enucleation following previous biopsy and diagnosis of hemangiosarcoma (not performed at COPLOW). One sample had concurrent lymphoplasmacytic and eosinophilic ulcerative keratitis. One globe had solar elastosis of the cornea. No follow-up information was available for any of the equine cases.
| DISCUSSION
Primary corneal neoplasms are rare. Most tumors of the cornea represent extension from conjunctival, intraocular, or limbal masses. Published cases of primary corneal neoplasms in veterinary species include squamous cell carcinoma, hemangioma, hemangiosarcoma, lymphangioma, lymphangiosarcoma, papilloma, adenocarcinoma, angiokeratoma, and lymphoma. 17, 30 The most common primary corneal neoplasms in veterinary species are viral papilloma and squamous cell carcinoma, predominantly occurring in horses and cattle, and less often in cats and dogs. 10, 18 In health, the cornea is an avascular structure in most species. Blood vessels migrate in from the sclera, or rarely from the iris, when there is corneal disease, such as a hypoxia, an ulcer, or sequestrum, to facilitate healing. 3 Preventing permanent vascularization of the cornea is an important area of research in both human and veterinary medicine, as vascularity may be associated with decreased vision. There is also risk of corneal graft rejection secondary to exposure of the normally nonvascular cornea to circulating immune cells and cytokines, and therefore loss of antigenic privilege. 2, 5, 31 Not only is the presence of blood vessels detrimental to vision, but these resident blood vessels, when present on a background of chronic inflammation, may have the propensity to develop into vascular neoplasms through the mechanisms of initiation and promotion. 3, 6 The new blood vessels that form on the cornea secondary to inflammation or hypoxia never completely regress. 3 It seems possible that, in a subset of patients, neoplastic transformation of these blood vessels could occur. Proangiotic molecules include vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), macrophage migratory inhibitory factor, basic fibroblast growth factor (bFGF), and angiopoietin, many of which are also associated with chronic inflammation. 5 Chronic inflammatory conditions may result in a rich milieu of proangiotic molecules and growth factors that favor the proliferation of reactive as well as neoplastic blood vessels. With time, and the initiator and promotor steps discussed previously such as UV radiation or immune-suppressive and modulatory drugs, there is the potential for an inflammatory vascular proliferation to transform into a neoplastic one.
The theory of inflammation predisposing to neoplasia is not new. In 1863, Virchow hypothesized that the origin of cancer was at sites of chronic inflammation, in part based on his hypothesis that some classes of irritants (what we would now call initiators), together with the tissue injury and ensuing inflammation they cause (promotors), enhance cell proliferation. 32 The presence of a chronic inflammatory microenvironment has been implicated in the development of multiple tumor types in multiple species. These include vaccine-associated sarcoma in cats, 33 post-traumatic ocular sarcoma in cats, 18 small cell epitheliotropic lymphoma in the gastrointestinal tract of cats with chronic inflammatory bowel disease, 34 urothelial and vascular urinary bladder tumors in cattle with chronic bracken fern ingestion, 8 Spirocerca lupi infection-associated esophageal fibrosarcoma in dogs, 35 and corneal squamous cell carcinoma associated with chronic inflammation and topical steroid/ immune-suppressive drug administration in dogs. 18 Pre-existing ocular surface disease is thought to predispose to the development of corneal neoplasia, although the exact pathogenesis is incompletely understood. Theories put forth include increased presence of inflammatory cytokines, vascular proliferation mediators, and cell growth regulators associated with local inflammation and healing. In a publication by Dreyfus et al on corneal squamous cell carcinoma, many of the cases had a history of chronic corneal disease and treatment with immune-modulating drugs such as prednisone or cyclosporine. 18 In this case series of history provided for the 3 equine cases was that one horse had a previous biopsy result of hemangiosarcoma; however, one case had solar elastosis identified histologically, suggesting UV-induced damage as a predisposing factor. Two additional canine cases also had solar elastosis, and one case had corneal epithelial dysplasia. No feline cases in this series had solar elastosis, and solar elastosis was not identified in feline patients in a case series of 21 cases of corneal squamous cell carcinoma (Leandro B.C. Teixeira and Richard R. unpublished data). It appears that solar elastosis is rare in the feline cornea. Three cases in dogs and 2 in cats specifically described abnormal corneal vascular proliferation in the clinical history, including neovascularization, pannus, granulation tissue, or an organizing vascular proliferation. This is a total of 14 of 22 cases (63.6%, almost two-thirds of all cases) having pre-existing inflammation or corneal damage which could be a predisposing factor for developing corneal vascular neoplasia. It should be noted that eight cases (5 dogs, 2 cats, and 1 horse) also had variable types of corneal or conjunctival inflammation noted histologically, but it is difficult to determine what inflammation was caused by the presence of a neoplasm and secondary ulceration, possible bacterial infection, etc., and what might have been preexisting, if the clinical history did not specifically mention pre-existing inflammation or ocular disease, so these cases were not included in the tally.
In this case series, 8 of 22 vascular tumors (36.3%) were situated centrally on the cornea, without attachment to the limbus grossly or microscopically: 5 canine cases, and 3 feline cases (all equine cases had limbal attachment). Of these 8 cases, 5 were hemangiomas (4 in dogs and 1 in one cat, 5/8, 62.5%) and 3 were hemangiosarcomas (1 dog and 2 cats, 3/8, 37.5%). The clinical or statistical significance of this trend toward benign tumors being centrally located is not clear, and the low number of cases overall limits interpretation.
In canine patients, four cases with a history of corneal surface disease had malignant tumors (4/10 = 40%), and six had benign tumors (6/10 = 60%). In cats, all those with a history of pre-existing corneal disease had malignant tumors (4/4 = 100%). Although these numbers are low, there appears to be a slight trend in dogs with pre-existing corneal disease to develop benign tumors, while in cats, the trend is toward malignant tumors. No analysis could be performed on the 3 equine cases because of the sparsity of clinical history and low number of cases.
It would seem most logical that corneal neoplasms arise from sclerally derived blood vessels and then grow inward and over the cornea, but in this subset of 8 cases, this appears not to be the case. In at least some of these cases, those with pre-existing ocular surface disease such as proliferative keratitis where neovascularization is common, neoplasms could be arising from resident "ghost vessels" left over from prior injury or corneal disease. There did not appear to be any tumors derived from iris-derived blood vessels penetrating the cornea from inside the eye secondary to anterior synechia; none of the tumors in this case series penetrated Descemet's membrane or appeared to be within the anterior chamber. Two canine cases had pre-iridal fibrovascular membranes, but anterior synechia was not observed in the sections reviewed. As far as tumors with limbal attachment, it is not clear why these tumors grew predominantly over the cornea, where in health, anti-angiotic factors work to prevent vascularization, instead of back onto the conjunctiva where it is normal to find blood vessels. Clearly, some imbalance of the proangiotic and anti-angiotic factors was present, a process which is only partially understood, but in which chronic inflammation and its associated growth factors and cytokines likely played a role in at least a subset of the cases.
Etiologies behind certain breed dispositions for vascular tumors of the globe and ocular adnexa include coat and eye color (dog, cat, and horse breeds with white faces, nonpigmented conjunctiva, and eyelids), those with increased solar exposure (farm breed and working breed dogs that spend a majority of their time outdoors, cats that sunbathe, and horses that are primarily housed outdoors without shade, patients living at high altitudes), and breeds at increased risk of developing chronic keratitis (brachycephalic breeds with prominent eyes and German shepherds). 15, 17, 21 German shepherds represented 2 of the 14 canine cases in this series, and a previously published case of corneal hemangiosarcoma was also a German shepherd. 23 Other breeds represented in this series are typically working dog types (Australian shepherd and border collie), but it is not known whether they were truly working dogs housed outside, or not. Housing and occupation of these patients were not available on the clinical history sheet; however, two canine cases in this series, and one equine case, had evidence of solar-induced corneal damage, characterized by solar elastosis in the cornea adjacent and subjacent to the neoplasm, and one additional case had corneal epithelial dysplasia, which can be, but is not always, induced by UV exposure. UV light has been documented as a predisposing factor in many neoplastic processes including corneal neoplasia and is one of the most wellstudied and understood initiators of neoplasia. Many proteins associated with vascular growth and proliferation have been studied in an attempt to identify pathways for which topical therapeutic intervention might be possible in the treatment of disorders of corneal neovascularization. Other treatment modalities such as cryotherapy and laser diathermy may be effective at eliminating abnormal blood vessels, but also cause corneal scarring, which is detrimental to vision. 17 Molecules that have been studied as possibly targets for pharmaceutical treatment include vascular endothelial growth factor (VEGF), basic fibroblast growth factor, and IL-12, which are all stimulatory to endothelial cell growth. [36] [37] [38] [39] [40] [41] Ambati et al 42 demonstrated
evidence that the expression of a soluble form of VEGFR1 in the normal cornea directly results in a lack of corneal blood vessels. Work by Cursiefen et al 43 supports VEGFR3 as the primary mediator of corneal avascularity in mice. The roles of IL-12, VEGF, VEGFR1, VEGFR2, and VEGFR-3 and other related cytokines in the development or treatment of corneal vascular tumors in veterinary species are not known. It would be interesting to study IL-12, VEGF, VEGFR1, VEGFR2, and VEGFR-3 expression in globes with corneal vascular tumors, with and without pre-existing ocular disease, to see whether there was a difference in expression. This knowledge could prove useful in the consideration for treating cases of ocular vascular disease pharmacologically with antiangiogenetic cytokines and chemokines, either as a primary treatment or as an adjunct therapy to keratectomy. This could possibly allow sparing of enucleation procedures, decrease scarring associated with treatments such as cryotherapy and laser, and allow the greatest preservation of vision.
Prognosis of ocular (conjunctival, corneal, or eyelid) vascular tumors in canines, felines, and equines appears to depend on the size and extent of the lesion and ability to obtain clean margins. 21, [22] [23] [24] [25] [26] Treatment is via keratectomy, enucleation, or exenteration, with or without adjuvant therapies such as strontium-90 beta (90Sr-b) plesiotherapy, cryotherapy, CO2 laser, and/or cautery, depending on the adequacy of surgical excision and feasibility of acquiring clean margins. 45, 46 Marginally or incompletely excised benign and malignant vascular tumors may recur. 17 Malignant tumors of the cornea and conjunctiva may spread to involve the third eyelid as well as the palpebra and periocular skin. Keratectomy or enucleation with clean margins provided a cure in reported cases of canine and feline corneal vascular neoplasia (as far as follow-up information was known for a particular patient, which varied from 3 months to 21 months), 23, 25, 26 although metastatic disease was reported in one canine case of corneal hemangiosarcoma included in a large study of visceral and nonvisceral hemangiosarcoma, and one other patient was euthanized following rapid recurrence of the tumor. 24 Completeness of excision was not information that was provided in that case series, so it is not clear whether clean margins were achieved, or not. Because there are no reported cases of primary corneal vascular neoplasia in horses, it is difficult to accurately predict long-term prognosis, and even for canine and feline cases, the sparsity of cases makes generalizations difficult. In reported cases of generalized "ocular angiosarcoma" with corneal involvement in horses, which includes malignant tumors of both lymphatic and blood vessel origin, some authors report no recurrence or evidence of metastatic disease up to twenty-one months after surgery, 27 and others describe aggressive surgery which may provide long-term local control (up to 2 years) but eventually there is either local regrowth, and/or local and distant metastatic disease, resulting in euthanasia. 11, 22, [28] [29] [30] Surgical removal in combination with cryotherapy or beta radiation did not successfully treat equine ocular hemangiosarcomas in one reported series of 4 cases, 29 but the number of cases is too low for meaningful extrapolation as to the efficacy of these ancillary treatments, and this publication is over 30 years old so it is possible that therapeutic interventions have improved in this time. The exact rate or risk of metastatic disease for corneal vascular neoplasia in any species is difficult to predict because of the sparsity of cases. More information could be obtained by getting follow-up information for each patient in this case series as to whether there was recurrence, metastatic disease, and the clinical outcome for each patient, but patients are often lost to follow-up. Based on the literature, horses in particular seem to have frequent postsurgical morbidity (typically in the form of colic or fracture) that limits their survivability even following apparent successful removal of the tumor, 29 so it is difficult to predict the long-term potential for metastatic disease.
Neoplasms of vascular and lymphatic origin, and even some atypical variants of squamous cell carcinoma, can be difficult to differentiate from each other with routine staining. Even with immunohistochemistry, the histiogenesis of a tumor sometimes cannot be conclusively determined. 22 Immunohistochemical markers for endothelial cells include CD31 and factor VIII, but both benign and malignant vascular and lymphatic neoplasms are immunopositive for these two endothelial markers. Negative labeling for cytokeratin markers such as cytokeratin AE1/3 rules out atypical vascularized variants of squamous cell carcinoma. 18 Many vascular tumors will have positive reactivity for smooth muscle actin (SMA) of the vessel wall, due to the presence of perivascular smooth muscle, a feature not found in vessels of lymphatic origin. 17 Histologically, the presence of erythrocytes within vascular spaces can help to differentiate hemangiomas and hemangiosarcomas from tumors of lymphatic origin (lymphangioma and lymphangiosarcoma), in which vascular spaces appear empty or contain only a few red blood cells, but this finding can be equivocal or subjective. Endothelial cells lining lymphatic spaces will be positive for Lyve-1 and Prox-1 by immunohistochemistry, but vascular endothelial cells should be negative for these markers, making these two markers helpful in differentiating hemangiosarcoma from lymphangiosarcoma. 46 There are many limitations to this retrospective study. Tumors were considered "primary corneal" if less than 10% of the mass was present on the limbus. This may inadvertently include tumors that are truly of conjunctival origin and, for whatever reason, grew predominantly on the cornea rather than onto the scleral/conjunctival surface. There are no follow-up data on the patients, so the recurrence or metastatic rates are not known. Only the clinical history provided on the submission forms is available for interpretation; a lack of clinical history provided does not rule out the presence of pre-existing ocular surface disease. An interpretation of hemangioma or hemangiosarcoma was based on the presence of blood-filled vascular spaces lined by spindle cells. Only one canine case had immunohistochemistry performed, and only one marker was used (factor VIII), which is not specific only for vascular endothelium, but will also label lymphatic cells. This may have inadvertently resulted in the inclusion of blood-rich lymphangiosarcomas in the case series. In order to conclusively confirm a vascular origin, a panel of CD31, factor VIII, SMA, Lyve-1, and Prox-1 would have to be used for each case, which was not economically feasible.
Primary corneal vascular neoplasia is rare in all species, likely in large part because normally, the cornea does not contain any blood vessels in most species including dogs, cats, horses, and humans. In the literature at this time, there are 3 reports in dogs, 2 reports in cats, and no reports in horses. This case series represents the largest collection of primary corneal vascular neoplasia published to date. Even as such, this collection of cases only represented 22 of 27 565 or 0.08% cases submitted to COPLOW over an 8-year time span, reflecting the rarity of this diagnosis. Like other types of neoplasia in general and corneal neoplasia specifically, chronic inflammation appears to be a predisposing factor for the development of corneal vascular neoplasia. Unlike visceral hemangiosarcoma, malignant corneal vascular tumors excised with clean margins may be associated with a good long-term prognosis. Additional research into the chemical and cytokine profile of chronic inflammation in the eye and on the ocular surface may provide additional information regarding potential therapeutic interventions for the prevention and treatment of corneal neovascularization, which is hypothesized to be a predisposing factor for the development of corneal vascular neoplasia. Biologic and pharmacologic anti-angiotic drugs may have some place in the treatment modalities for corneal vascular neoplasia. Even though vascular tumors of the cornea are rare and unexpected based on the normally avascular state of the cornea, this differential diagnosis should be considered for tumors of the central cornea in dogs, cats, and horses.
